News and notices. December 22, 2014

Case study: How a Mexico clinic uses anti-VEGF drugs

Pedro A Gomez Bastar CBM Medical Adviser and Chairman, Mexico, answers 5 key questions on how the Instituto de la Visión de Montemorelos in Mexico uses anti-VEGF drugs for the prevention of blindness:

  1. Which anti-VEGF agents do we use?
  2. What are the indications?
  3. Who gives the injections?
  4. Are anti-VEGF agents used without OCT?
  5. What are the outcomes?

Read the full article: “Use of anti-VEGF drugs at the Instituto de la Visión de Montemorelos”